ILA island pharmaceuticals limited

Ann: Completion of patient dosing in Phase 2b clinical trial, page-6

  1. 8,239 Posts.
    lightbulb Created with Sketch. 2061
    It’s good that oppies expire before results. So investors have to exercise before knowing the results so it beings in the cash irrespective of the results. As an investor I would have preferred to exercise oppies after results to minimise the risk however as the prophalyctic arm has already given positive results and the MC is quite low it just makes sense to exercise irrespective of the therapeutic arm results. (Btw I have exercised my oppies which are part of today’s Ann.)

    I have high hopes for the therapeutic arm as someone who has undergone Dengue before. I am told that a second dengue attack is deemed really bad and could be fatal. So really hoping that we have a cure given the increased risk of mosquito borne diseases.

    DYOR. No advice. Just a hopeful SH
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
14.5¢
Change
0.010(7.41%)
Mkt cap ! $34.23M
Open High Low Value Volume
13.5¢ 14.5¢ 13.5¢ $54.18K 388.9K

Buyers (Bids)

No. Vol. Price($)
3 145593 14.5¢
 

Sellers (Offers)

Price($) Vol. No.
15.0¢ 5000 1
View Market Depth
Last trade - 15.43pm 20/06/2025 (20 minute delay) ?
ILA (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.